Biomarkers of Bipolar Disorder in Late Life: An Evidence-Based Systematic Review

Purpose of Review Review the current evidence on biomarkers for bipolar disorder in the older adults. We conducted a systematic search of PubMed MEDLINE, PsycINFO, and Web of Science databases using the MeSH search terms "Biomarkers", "Bipolar Disorder", "Aged" and and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current psychiatry reports 2024-03, Vol.26 (3), p.78-103
Hauptverfasser: Chancel, R., Lopez-Castroman, J., Baca-Garcia, E., Mateos Alvarez, R., Courtet, Ph, Conejero, I.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 103
container_issue 3
container_start_page 78
container_title Current psychiatry reports
container_volume 26
creator Chancel, R.
Lopez-Castroman, J.
Baca-Garcia, E.
Mateos Alvarez, R.
Courtet, Ph
Conejero, I.
description Purpose of Review Review the current evidence on biomarkers for bipolar disorder in the older adults. We conducted a systematic search of PubMed MEDLINE, PsycINFO, and Web of Science databases using the MeSH search terms "Biomarkers", "Bipolar Disorder", "Aged" and and “Aged, 80 and over”. Studies were included if they met the following criteria: (1) the mean age of the study population was 50 years old or older, (2) the study included patients with bipolar disorder, and (3) the study examined one type of biomarkers or more including genetic, neuroimaging, and biochemical biomarkers. Reviews, case reports, studies not in English and studies for which no full text was available were excluded. A total of 26 papers were included in the final analysis. Recent Findings Genomic markers of bipolar disorder in older adults highlighted the implication of serotonin metabolism, while the expression of genes involved in angiogenesis was dysregulated. Peripheral blood markers were mainly related with low grade inflammation, axonal damage, endothelial dysfunction, and the dysregulation of the HPA axis. Neuroanatomical markers reflected a dysfunction of the frontal cortex, a loss of neurones in the anterior cingulate cortex and a reduction of the hippocampal volume (in patients older than 50 years old). While not necessarily limited to older adults, some of them may be useful for differential diagnosis (neurofilaments), disease staging (homocysteine, BDNF) and the monitoring of treatment outcomes (matrix metalloproteinases). Summary Our review provides a comprehensive overview of the current evidence on biomarkers for bipolar disorder in the older adults. The identification of biomarkers may aid in the diagnosis, treatment selection, and monitoring of bipolar disorder in older adults, ultimately leading to improved outcomes for this population. Further research is needed to validate and further explore the potential clinical utility of biomarkers in this population.
doi_str_mv 10.1007/s11920-024-01483-7
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04731183v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2963824267</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-a940ccc060941188dffc2858c8378683c0a080341ea4dc1f80a06a2593da8ddf3</originalsourceid><addsrcrecordid>eNp9kUtv1DAURq0K1JbSP8ACWWJTFobrRxKH3UwfFCkSCOjacu0bcMnEUzszqP--nqYUiQUrv879rq8OIa84vOMAzfvMeSuAgVAMuNKSNXvkkFeyYrxW1bPdXkgmNRcH5EXONwACQIt9ciC1aqCq2kPyZRniyqZfmDKNPV2GdRxsomchx-Qx0TDSzk5Iu9DjB7oY6fk2eBwdsqXN6Om3uzzhyk7B0a-4Dfj7JXne2yHj8eN6RK4uzr-fXrLu88dPp4uOOQXtxGyrwDkHNbSKc6193zuhK-20bHStpQMLGqTiaJV3vNflXFtRtdJb7X0vj8jbOfenHcw6hTLEnYk2mMtFZ3Z3oBpZkuWWF_ZkZtcp3m4wT2YVssNhsCPGTTairerSs4G2oG_-QW_iJo1lkkLVUgsl6qZQYqZcijkn7J9-wMHs3JjZjSluzIMbsyt6_Ri9uV6hfyr5I6MAcgZyeRp_YPrb-z-x9964llA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2963824267</pqid></control><display><type>article</type><title>Biomarkers of Bipolar Disorder in Late Life: An Evidence-Based Systematic Review</title><source>Springer Nature - Complete Springer Journals</source><creator>Chancel, R. ; Lopez-Castroman, J. ; Baca-Garcia, E. ; Mateos Alvarez, R. ; Courtet, Ph ; Conejero, I.</creator><creatorcontrib>Chancel, R. ; Lopez-Castroman, J. ; Baca-Garcia, E. ; Mateos Alvarez, R. ; Courtet, Ph ; Conejero, I.</creatorcontrib><description>Purpose of Review Review the current evidence on biomarkers for bipolar disorder in the older adults. We conducted a systematic search of PubMed MEDLINE, PsycINFO, and Web of Science databases using the MeSH search terms "Biomarkers", "Bipolar Disorder", "Aged" and and “Aged, 80 and over”. Studies were included if they met the following criteria: (1) the mean age of the study population was 50 years old or older, (2) the study included patients with bipolar disorder, and (3) the study examined one type of biomarkers or more including genetic, neuroimaging, and biochemical biomarkers. Reviews, case reports, studies not in English and studies for which no full text was available were excluded. A total of 26 papers were included in the final analysis. Recent Findings Genomic markers of bipolar disorder in older adults highlighted the implication of serotonin metabolism, while the expression of genes involved in angiogenesis was dysregulated. Peripheral blood markers were mainly related with low grade inflammation, axonal damage, endothelial dysfunction, and the dysregulation of the HPA axis. Neuroanatomical markers reflected a dysfunction of the frontal cortex, a loss of neurones in the anterior cingulate cortex and a reduction of the hippocampal volume (in patients older than 50 years old). While not necessarily limited to older adults, some of them may be useful for differential diagnosis (neurofilaments), disease staging (homocysteine, BDNF) and the monitoring of treatment outcomes (matrix metalloproteinases). Summary Our review provides a comprehensive overview of the current evidence on biomarkers for bipolar disorder in the older adults. The identification of biomarkers may aid in the diagnosis, treatment selection, and monitoring of bipolar disorder in older adults, ultimately leading to improved outcomes for this population. Further research is needed to validate and further explore the potential clinical utility of biomarkers in this population.</description><identifier>ISSN: 1523-3812</identifier><identifier>EISSN: 1535-1645</identifier><identifier>DOI: 10.1007/s11920-024-01483-7</identifier><identifier>PMID: 38470559</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Aged ; Aged, 80 and over ; Biomarkers ; Bipolar Disorder ; Humans ; Hypothalamo-Hypophyseal System ; Inflammation ; Life Sciences ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Older people ; Pituitary-Adrenal System ; Psychiatry ; Systematic review ; Topical Collection on Mood Disorders</subject><ispartof>Current psychiatry reports, 2024-03, Vol.26 (3), p.78-103</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><rights>Copyright</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-a940ccc060941188dffc2858c8378683c0a080341ea4dc1f80a06a2593da8ddf3</citedby><cites>FETCH-LOGICAL-c409t-a940ccc060941188dffc2858c8378683c0a080341ea4dc1f80a06a2593da8ddf3</cites><orcidid>0000-0002-6519-8586 ; 0000-0002-9142-1278 ; 0000-0003-0618-0690 ; 0000-0002-6963-6555 ; 0009-0009-3741-7508</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11920-024-01483-7$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11920-024-01483-7$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38470559$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-04731183$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Chancel, R.</creatorcontrib><creatorcontrib>Lopez-Castroman, J.</creatorcontrib><creatorcontrib>Baca-Garcia, E.</creatorcontrib><creatorcontrib>Mateos Alvarez, R.</creatorcontrib><creatorcontrib>Courtet, Ph</creatorcontrib><creatorcontrib>Conejero, I.</creatorcontrib><title>Biomarkers of Bipolar Disorder in Late Life: An Evidence-Based Systematic Review</title><title>Current psychiatry reports</title><addtitle>Curr Psychiatry Rep</addtitle><addtitle>Curr Psychiatry Rep</addtitle><description>Purpose of Review Review the current evidence on biomarkers for bipolar disorder in the older adults. We conducted a systematic search of PubMed MEDLINE, PsycINFO, and Web of Science databases using the MeSH search terms "Biomarkers", "Bipolar Disorder", "Aged" and and “Aged, 80 and over”. Studies were included if they met the following criteria: (1) the mean age of the study population was 50 years old or older, (2) the study included patients with bipolar disorder, and (3) the study examined one type of biomarkers or more including genetic, neuroimaging, and biochemical biomarkers. Reviews, case reports, studies not in English and studies for which no full text was available were excluded. A total of 26 papers were included in the final analysis. Recent Findings Genomic markers of bipolar disorder in older adults highlighted the implication of serotonin metabolism, while the expression of genes involved in angiogenesis was dysregulated. Peripheral blood markers were mainly related with low grade inflammation, axonal damage, endothelial dysfunction, and the dysregulation of the HPA axis. Neuroanatomical markers reflected a dysfunction of the frontal cortex, a loss of neurones in the anterior cingulate cortex and a reduction of the hippocampal volume (in patients older than 50 years old). While not necessarily limited to older adults, some of them may be useful for differential diagnosis (neurofilaments), disease staging (homocysteine, BDNF) and the monitoring of treatment outcomes (matrix metalloproteinases). Summary Our review provides a comprehensive overview of the current evidence on biomarkers for bipolar disorder in the older adults. The identification of biomarkers may aid in the diagnosis, treatment selection, and monitoring of bipolar disorder in older adults, ultimately leading to improved outcomes for this population. Further research is needed to validate and further explore the potential clinical utility of biomarkers in this population.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biomarkers</subject><subject>Bipolar Disorder</subject><subject>Humans</subject><subject>Hypothalamo-Hypophyseal System</subject><subject>Inflammation</subject><subject>Life Sciences</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Older people</subject><subject>Pituitary-Adrenal System</subject><subject>Psychiatry</subject><subject>Systematic review</subject><subject>Topical Collection on Mood Disorders</subject><issn>1523-3812</issn><issn>1535-1645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kUtv1DAURq0K1JbSP8ACWWJTFobrRxKH3UwfFCkSCOjacu0bcMnEUzszqP--nqYUiQUrv879rq8OIa84vOMAzfvMeSuAgVAMuNKSNXvkkFeyYrxW1bPdXkgmNRcH5EXONwACQIt9ciC1aqCq2kPyZRniyqZfmDKNPV2GdRxsomchx-Qx0TDSzk5Iu9DjB7oY6fk2eBwdsqXN6Om3uzzhyk7B0a-4Dfj7JXne2yHj8eN6RK4uzr-fXrLu88dPp4uOOQXtxGyrwDkHNbSKc6193zuhK-20bHStpQMLGqTiaJV3vNflXFtRtdJb7X0vj8jbOfenHcw6hTLEnYk2mMtFZ3Z3oBpZkuWWF_ZkZtcp3m4wT2YVssNhsCPGTTairerSs4G2oG_-QW_iJo1lkkLVUgsl6qZQYqZcijkn7J9-wMHs3JjZjSluzIMbsyt6_Ri9uV6hfyr5I6MAcgZyeRp_YPrb-z-x9964llA</recordid><startdate>20240301</startdate><enddate>20240301</enddate><creator>Chancel, R.</creator><creator>Lopez-Castroman, J.</creator><creator>Baca-Garcia, E.</creator><creator>Mateos Alvarez, R.</creator><creator>Courtet, Ph</creator><creator>Conejero, I.</creator><general>Springer US</general><general>Springer Nature B.V</general><general>Current Medicine Group</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-6519-8586</orcidid><orcidid>https://orcid.org/0000-0002-9142-1278</orcidid><orcidid>https://orcid.org/0000-0003-0618-0690</orcidid><orcidid>https://orcid.org/0000-0002-6963-6555</orcidid><orcidid>https://orcid.org/0009-0009-3741-7508</orcidid></search><sort><creationdate>20240301</creationdate><title>Biomarkers of Bipolar Disorder in Late Life: An Evidence-Based Systematic Review</title><author>Chancel, R. ; Lopez-Castroman, J. ; Baca-Garcia, E. ; Mateos Alvarez, R. ; Courtet, Ph ; Conejero, I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-a940ccc060941188dffc2858c8378683c0a080341ea4dc1f80a06a2593da8ddf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biomarkers</topic><topic>Bipolar Disorder</topic><topic>Humans</topic><topic>Hypothalamo-Hypophyseal System</topic><topic>Inflammation</topic><topic>Life Sciences</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Older people</topic><topic>Pituitary-Adrenal System</topic><topic>Psychiatry</topic><topic>Systematic review</topic><topic>Topical Collection on Mood Disorders</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chancel, R.</creatorcontrib><creatorcontrib>Lopez-Castroman, J.</creatorcontrib><creatorcontrib>Baca-Garcia, E.</creatorcontrib><creatorcontrib>Mateos Alvarez, R.</creatorcontrib><creatorcontrib>Courtet, Ph</creatorcontrib><creatorcontrib>Conejero, I.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Current psychiatry reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chancel, R.</au><au>Lopez-Castroman, J.</au><au>Baca-Garcia, E.</au><au>Mateos Alvarez, R.</au><au>Courtet, Ph</au><au>Conejero, I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biomarkers of Bipolar Disorder in Late Life: An Evidence-Based Systematic Review</atitle><jtitle>Current psychiatry reports</jtitle><stitle>Curr Psychiatry Rep</stitle><addtitle>Curr Psychiatry Rep</addtitle><date>2024-03-01</date><risdate>2024</risdate><volume>26</volume><issue>3</issue><spage>78</spage><epage>103</epage><pages>78-103</pages><issn>1523-3812</issn><eissn>1535-1645</eissn><abstract>Purpose of Review Review the current evidence on biomarkers for bipolar disorder in the older adults. We conducted a systematic search of PubMed MEDLINE, PsycINFO, and Web of Science databases using the MeSH search terms "Biomarkers", "Bipolar Disorder", "Aged" and and “Aged, 80 and over”. Studies were included if they met the following criteria: (1) the mean age of the study population was 50 years old or older, (2) the study included patients with bipolar disorder, and (3) the study examined one type of biomarkers or more including genetic, neuroimaging, and biochemical biomarkers. Reviews, case reports, studies not in English and studies for which no full text was available were excluded. A total of 26 papers were included in the final analysis. Recent Findings Genomic markers of bipolar disorder in older adults highlighted the implication of serotonin metabolism, while the expression of genes involved in angiogenesis was dysregulated. Peripheral blood markers were mainly related with low grade inflammation, axonal damage, endothelial dysfunction, and the dysregulation of the HPA axis. Neuroanatomical markers reflected a dysfunction of the frontal cortex, a loss of neurones in the anterior cingulate cortex and a reduction of the hippocampal volume (in patients older than 50 years old). While not necessarily limited to older adults, some of them may be useful for differential diagnosis (neurofilaments), disease staging (homocysteine, BDNF) and the monitoring of treatment outcomes (matrix metalloproteinases). Summary Our review provides a comprehensive overview of the current evidence on biomarkers for bipolar disorder in the older adults. The identification of biomarkers may aid in the diagnosis, treatment selection, and monitoring of bipolar disorder in older adults, ultimately leading to improved outcomes for this population. Further research is needed to validate and further explore the potential clinical utility of biomarkers in this population.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>38470559</pmid><doi>10.1007/s11920-024-01483-7</doi><tpages>26</tpages><orcidid>https://orcid.org/0000-0002-6519-8586</orcidid><orcidid>https://orcid.org/0000-0002-9142-1278</orcidid><orcidid>https://orcid.org/0000-0003-0618-0690</orcidid><orcidid>https://orcid.org/0000-0002-6963-6555</orcidid><orcidid>https://orcid.org/0009-0009-3741-7508</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1523-3812
ispartof Current psychiatry reports, 2024-03, Vol.26 (3), p.78-103
issn 1523-3812
1535-1645
language eng
recordid cdi_hal_primary_oai_HAL_hal_04731183v1
source Springer Nature - Complete Springer Journals
subjects Aged
Aged, 80 and over
Biomarkers
Bipolar Disorder
Humans
Hypothalamo-Hypophyseal System
Inflammation
Life Sciences
Medicine
Medicine & Public Health
Middle Aged
Older people
Pituitary-Adrenal System
Psychiatry
Systematic review
Topical Collection on Mood Disorders
title Biomarkers of Bipolar Disorder in Late Life: An Evidence-Based Systematic Review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T18%3A19%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biomarkers%20of%20Bipolar%20Disorder%20in%20Late%20Life:%20An%20Evidence-Based%20Systematic%20Review&rft.jtitle=Current%20psychiatry%20reports&rft.au=Chancel,%20R.&rft.date=2024-03-01&rft.volume=26&rft.issue=3&rft.spage=78&rft.epage=103&rft.pages=78-103&rft.issn=1523-3812&rft.eissn=1535-1645&rft_id=info:doi/10.1007/s11920-024-01483-7&rft_dat=%3Cproquest_hal_p%3E2963824267%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2963824267&rft_id=info:pmid/38470559&rfr_iscdi=true